AUB ScholarWorks

Browsing Faculty of Medicine (FM) by Subject "ZIDOVUDINE"

Browsing Faculty of Medicine (FM) by Subject "ZIDOVUDINE"

Sort by: Order: Results:

  • Bazarbachi A.; Cwynarski K.; Boumendil A.; Finel H.; Fields P.; Raj K.; Nagler A.; Mohty M.; Sureda A.; Dreger P.; Hermine O. (LONDONMACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND, 2014)
    12 months had chronic GVHD. Overall these results indicate that allo-SCT but not auto-SCT may salvage a subset of ATL patients, supporting the existence of graft vs ATL effect also in non-Japanese patients.Bone Marrow ...
  • Hermine O.; Dombret H.; Poupon J.; Arnulf B.; Lefrere F.; Rousselot P.; Damaj G.; Delarue R.; Fermand J.P.; Brouet J.C.; Degos L.; Varet B.; de The H.; Bazarbachi A. (LONDONMACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND, 2004)
    Human T-cell lymphotropic virus type 1 associated adult T-cell leukemia-lymphoma carries a very poor prognosis due to its intrinsic resistance to chemotherapy. Although zidovudine (AZT) and α -interferon (IFN) yield some ...
  • Marcais A.; Suarez F.; Sibon D.; Frenzel L.; Hermine O.; Bazarbachi A. (NEW YORK233 SPRING ST, NEW YORK, NY 10013 USA, 2013)
    Adult T-cell leukemia-lymphoma (ATL) is the first human malignancy associated with a retroviral infection and occurs in approximately 5 percent of the 15 million to 20 million people infected by human T-cell lymphotropic ...

Search AUB ScholarWorks


My Account